Matthew E. Bahamonde, Ph.D. - Publications
Affiliations: | 2002 | University of California, Los Angeles, Los Angeles, CA |
Area:
Genetics, Molecular Biology, Animal Physiology BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2006 | Gamradt SC, Abe N, Bahamonde ME, Lee YP, Nelson SD, Lyons KM, Lieberman JR. Tracking expression of virally mediated BMP-2 in gene therapy for bone repair. Clinical Orthopaedics and Related Research. 450: 238-45. PMID 16702923 DOI: 10.1097/01.Blo.0000223989.49400.A8 | 0.647 | |||
2003 | Délot EC, Bahamonde ME, Zhao M, Lyons KM. BMP signaling is required for septation of the outflow tract of the mammalian heart. Development (Cambridge, England). 130: 209-20. PMID 12441304 DOI: 10.1242/Dev.00181 | 0.51 | |||
2001 | Bahamonde ME, Lyons KM. BMP3: to be or not to be a BMP. The Journal of Bone and Joint Surgery. American Volume. 83: S56-62. PMID 11263666 DOI: 10.2106/00004623-200100001-00008 | 0.657 | |||
2001 | Daluiski A, Engstrand T, Bahamonde ME, Gamer LW, Agius E, Stevenson SL, Cox K, Rosen V, Lyons KM. Bone morphogenetic protein-3 is a negative regulator of bone density. Nature Genetics. 27: 84-8. PMID 11138004 DOI: 10.1038/83810 | 0.66 | |||
2001 | Bahamonde ME, Lyons KM. BMP3: To be or not to be a BMP Journal of Bone and Joint Surgery - Series A. 83. | 0.655 | |||
2000 | Engstrand T, Daluiski A, Bahamonde ME, Melhus H, Lyons KM. Transient production of bone morphogenetic protein 2 by allogeneic transplanted transduced cells induces bone formation. Human Gene Therapy. 11: 205-11. PMID 10646651 DOI: 10.1089/10430340050016274 | 0.626 | |||
Show low-probability matches. |